Abstract Thomas J Dougherty from Roswell Park Cancer Center played a major role in the
progress of photodynamic therapy (PDT) from a laboratory science into a real‐world clinical …

BODIPY dyes tend to be highly fluorescent, but their emissions can be attenuated by adding
substituents with appropriate oxidation potentials. Substituents like these have electrons to …

IR780, a molecule with a strong optical absorption and emission in the near infrared (NIR)
region, is receiving an increasing attention from researchers working in the area of cancer …

Photodynamic therapy (PDT) and photothermal therapy (PTT) have gained considerable
attention as potential alternatives to conventional cancer treatments. However, these …

The photosensitizer Chlorin e6 (Ce6) has been frequently employed for photodynamic
therapy (PDT) of cancer; however, its nonspecific toxicity has limited its clinical applications …

Over the past decades, medicine has made enormous progress, revolutionized by modern
technologies and innovative therapeutic approaches. One of the most exciting branches of …

Cancer and drug-resistant superinfections are common and serious problems afflicting
millions worldwide. Photodynamic therapy (PDT) is a successful and clinically approved …

Bladder cancer is a common disease with a high recurrence rate. In order to improve the
treatment of superficial bladder tumors, we evaluated the efficacy and safety of transurethral …

The development of visual tumor theranostic nanoparticles has become a great challenge.
In this study, D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) was conjugated to …

This paper describes the results of our extensive and continuing series of studies on the
development and investigation of new potential sensitizers for antitumor and antimicrobial …